Memorial Sloan-Kettering Opens Rockefeller Outpatient Pavilion

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 8 No 8
Volume 8
Issue 8

NEW YORK-Memorial Sloan-Kettering Cancer Center’s new Laurance S. Rockefeller Outpatient Pavilion provides advanced programs for outpatient cancer diagnosis and treatment in a calm and beautiful environment. “We believe this facility will serve as a national model for the delivery of outpatient cancer care in the new millennium,” said Paul A. Marks, MD, president and CEO.

NEW YORK—Memorial Sloan-Kettering Cancer Center’s new Laurance S. Rockefeller Outpatient Pavilion provides advanced programs for outpatient cancer diagnosis and treatment in a calm and beautiful environment. “We believe this facility will serve as a national model for the delivery of outpatient cancer care in the new millennium,” said Paul A. Marks, MD, president and CEO.

The 190,000-square-foot facility is located at 53rd Street and Third Avenue in midtown Manhattan. Patient care services include gastrointestinal, genitourinary, gynecology (ovarian and cervical cancer); dermatology, thoracic oncology, clinical immunology, cardiology and pulmonary, radiology, and plastic and reconstructive surgery consultations, as well as pharmacy services, a boutique (see figure), and a conference center.

The physical environment is designed to convey a sense of peace and well-being, and includes several waterfalls, sculptural water gardens in 9 reception areas, and original works of art and poetry.

Other interesting aspects of the Rockefeller Pavilion include: organizing patient care services by specific diseases so that teams of specialists work together on the same floor; creating a technology infrastructure so that medical records and x-rays are tracked electronically and are easily available to members of the disease team; and providing patients with Internet access and a comprehensive patient education program with CD-ROMs.

Laurance S. Rockefeller, for whom the building is named, said: “This extraordinary new facility . . . stands as a symbol of our belief in the healing synergy between medical science and the power of each individual patient’s mind, body, and spirit.” Mr. Rockefeller is honorary co-chairman of the Boards of Overseers and Managers at Memorial Sloan-Kettering.

Recent Videos
The FirstLook liquid biopsy, when used as an adjunct to low-dose CT, may help to address the unmet need of low lung cancer screening utilization.
An 80% sensitivity for lung cancer was observed with the liquid biopsy, with high sensitivity observed for early-stage disease, as well.
9 Experts are featured in this series.
9 Experts are featured in this series.
Harmonizing protocols across the health care system may bolster the feasibility of giving bispecifics to those with lymphoma in a community setting.
2 experts are featured in this series.
Patients who face smoking stigma, perceive a lack of insurance, or have other low-dose CT related concerns may benefit from blood testing for lung cancer.
9 Experts are featured in this series.
Related Content